Aliases & Classifications for Alexia

About this section

Aliases & Descriptions for Alexia:

Name: Alexia 10 12 65
Dyslexia 36 65
Dyslexia, Acquired 65
 
Acquired Dyslexia 10
Aphemesthaesia 10

Classifications:



External Ids:

Disease Ontology10 DOID:13417
ICD9CM29 315.01
UMLS65 C0002018, C0013388

Summaries for Alexia

About this section
Disease Ontology:10 An agnosia that is a loss of the ability to recognize text.

MalaCards based summary: Alexia, also known as dyslexia, is related to cerebritis and agnosia, and has symptoms including hemiasomatognosia, altered pitch perception and autoscopy. An important gene associated with Alexia is PSEN1 (Presenilin 1), and among its related pathways are A-beta Signaling Pathways and Alzheimers Disease Pathway. Affiliated tissues include brain, b cells and t cells, and related mouse phenotypes are muscle and nervous system.

Related Diseases for Alexia

About this section

Diseases related to Alexia via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 73)
idRelated DiseaseScoreTop Affiliating Genes
1cerebritis29.5APOE, TARDBP
2agnosia11.3
3agraphia11.1
4visual verbal agnosia10.9
5dyslexia10.6
6aphasia10.3
7spermatogenic failure 1010.2APOE, PSEN1
8lipoprotein glomerulopathy10.1APOE, PSEN1
9dementia10.1
10prosopagnosia10.1
11bartholin's gland adenoma10.1MBP, PSEN1
12macular degeneration, age-related, 1110.1APOE, PSEN1
13posterior cortical atrophy10.1
14headache10.0APOE, MBP
15visual agnosia10.0
16candidiasis10.0APOE, PSEN1
17colon kaposi sarcoma10.0APOE, PSEN1
18semantic agnosia9.9PSEN1, TARDBP
19simultanagnosia9.9
20semantic dementia9.9
21auditory agnosia9.9PSEN1, TARDBP
22epidural abscess9.9PSEN1, TARDBP
23reflex sympathetic dystrophy9.9APOE, MBP
24bradyopsia9.9PSEN1, TARDBP
25mitochondrial metabolism disease9.9APOE, PSEN1
26basophil adenoma9.9PSEN1, TARDBP
27ftdals29.9PSEN1, TARDBP
28anosognosia9.9
29status epilepticus9.9
30acute disseminated encephalomyelitis9.9
31encephalitis9.9
32encephalopathy9.9
33actinobacillosis9.8PSEN1, TARDBP
34pigmentary cirrhosis9.8APOE, TARDBP
35tauopathy9.8PSEN1, TARDBP
36eczema herpeticum9.8APOE, PSEN1
37multiple sclerosis, disease progression, modifier of9.7APOE, MBP
38creutzfeldt-jakob disease9.7
39arteriovenous fistula9.7
40cerebral hemorrhage9.7
41temporal lobe epilepsy9.7
42amusia9.7
43associative agnosia9.7
44tactile agnosia9.7
45amblyopia9.7
46arteriovenous malformation9.7
47reading disorder9.7
48protein s deficiency9.7
49intraventricular meningioma9.7
50myopathy9.7

Graphical network of the top 20 diseases related to Alexia:



Diseases related to alexia

Symptoms for Alexia

About this section

UMLS symptoms related to Alexia:


hemiasomatognosia, altered pitch perception, autoscopy, seeing words, letters, or syllables reversed on page, symptoms, amimia, hemiapraxia, dyslexia (excl learning disorder), cortical dysfunction nec, neurologic neglect syndrome, specific learning problem, other and unspecified symbolic dysfunctions, visual agnosia, alexia and agraphia present, scanning speech

Drugs & Therapeutics for Alexia

About this section

Drugs for Alexia (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 31)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Rivastigmineapproved, investigationalPhase 481123441-03-277991
Synonyms:
(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
123441-03-2
3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate
3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate
AB1004572
AC1L2U92
BIDD:GT0316
C11766
CHEMBL636
CID77991
Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester
Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
D03822
DB00989
ENA 713 free base
Ena 713 Free Base
 
Ethylmethylcarbamic acid 3-((1S)-1-(dimethylamino)ethyl)phenyl ester
Exelon
Exelon Patch
HMS2089H18
I06-2037
LS-172571
MolPort-003-666-662
NCGC00167531-01
Rivastigmine
Rivastigmine (JAN/USAN/INN)
Rivastigmine Hydrogen Tartrate
Rivastigmine [USAN:INN]
Rivastigmine hydrogen tartrate
SDZ 212-713
UNII-PKI06M3IW0
[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate
m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate
rivastigmine
2Protective AgentsPhase 45651
3Neurotransmitter AgentsPhase 414795
4Neuroprotective AgentsPhase 41376
5Cholinesterase InhibitorsPhase 4498
6Cholinergic AgentsPhase 43243
7Imatinib MesylatePhase 4577123596
8
TolvaptanapprovedPhase 384150683-30-0216237, 443894
Synonyms:
( -)-4'-((7-Chloro-2,3,4,5-tetrahydro-5-hydroxy-1H-1-benzazepin-1-yl)carbonyl)-o-tolu-m-toluidide
150683-30-0
7-Chloro-5-hydroxy-1-(2-methyl-4-(2-methylbenzoylamino)benzoyl)2,3,4,5-tetrahydro-1H-1-benzazepine
AC1L50C9
C116664
CHEBI:327437
CHEMBL344159
CID216237
 
L001628
N-[4-(7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)-3-methylphenyl]-2-methylbenzamide
OPC 41061
OPC-41061
PDSP1_001738
PDSP2_001721
Samsca
Tolvaptan
UNII-21G72T1950
benzazepine derivative, 32
9
ZincapprovedPhase 314777440-66-623994, 32051
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
10
PancrelipaseapprovedPhase 388053608-75-6
Synonyms:
1,4-alpha-D- glucan glucanohydrolase
Creon
PA
Pancreatic alpha-amylase precursor
Pancreaze
 
Pancrelipase
Pertzye
Polocaine-mpf
Ultresa
Viokace
Zenpep
11
Insulin DetemirapprovedPhase 3189169148-63-45311023
Synonyms:
Insulin detemir
Insulin detemir recombinant
Levemir
 
Levemir flexpen
Levemir innolet
Levemir penfill
NN-304
12pancreatinPhase 3880
13Insulin, Long-ActingPhase 3123
14Insulin, Globin ZincPhase 34278
15HormonesPhase 311748
16insulinPhase 34278
17Natriuretic AgentsPhase 31403
18Arginine VasopressinPhase 3264
19Hypoglycemic AgentsPhase 34503
20VasopressinsPhase 3260
21
IfosfamideapprovedPhase 1, Phase 23713778-73-23690
Synonyms:
(+-)-Ifosfamid
(+-)-Ifosphamide
(+-)-Tetrahydro-N,3-bis(2-chloroethyl)-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
(D,L)-Ifosfamide
(R,S)-Ifosphamide
(R,S)-N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
2,3-(N,N(sup 1)-Bis(2-chloroethyl)diamido)-1,3,2-oxazaphosphoridinoxyd
2,3-N,N(sup 1)-Bis(2-chloroethyl)diamido-1,3,2-oxazaphosphoridinoxyd
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis( 2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorin-2-amine, N,3-bis(2-chloroethyl)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-, 2-oxide (8CI)
2H-1,3,2-Oxazaphosphorine, 3-(2-chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-, 2-oxide
3,} 2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-((2-chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorine oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,3,2-oxazaphosphorineoxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2- oxide
3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]tetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
36341-88-5
3778-73-2
84711-20-6
A 4942
AB00513932
AC-2113
AC1L1GHW
ASTA Z 4942
Ambap3778-73-2
Asta Z 4942
BPBio1_000865
BRN 0611835
BSPBio_000785
C07047
CAS-3778-73-2
CCRIS 352
CHEBI:5864
CHEMBL1024
CID3690
Cyfos
D00343
D007069
DB01181
EINECS 223-237-3
HMS1570H07
HMS2090M12
HMS2093N07
HSDB 7023
Holoxan
Holoxan 1000
I-Phosphamide
I06-0494
IFEX (TN)
Ifex
Ifosfamid
Ifosfamida
Ifosfamida [INN-Spanish]
Ifosfamide
 
Ifosfamide (JAN/USP/INN)
Ifosfamide Sterile
Ifosfamide [USAN:INN:BAN:JAN]
Ifosfamidum
Ifosfamidum [INN-Latin]
Ifosphamide
Ifsofamide
Iphosphamid
Iphosphamid(e)
Iphosphamide
Iso Endoxan
Iso-Endoxan
Isoendoxan
Isofosfamide
Isophosphamide
Isosfamide
LS-102
LS-99799
MJF 9325
MJF-9325
MLS002154021
Mitoxana
Mitoxana, Ifex, Ifosfamide
MolPort-003-666-704
N,3-Bis(2-chloroethyl)-1,3,2-oxazaphosphinan-2-amine 2-oxide
N,3-Bis(2-chloroethyl)tetrahydro-2H-1,3,2-oxazaphosphorin-2-amine 2-oxide
N,N-Bis(beta-chloroethyl)-amino-N',O-propylene-phosphoric acid ester diamide
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid
N-(2-Chloraethyl)-N'-(2-chloraethyl)-N',O-propylen-phosphorsaureester-diamid [German]
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylen ephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylene phosphoric acid ester diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid diamide
N-(2-Chloroethyl)-N'-(2-chloroethyl)-N',O-propylenephosphoric acid ester diamide
N-(2-Chloroethyl)-N-(3-(2-chloroethyl)-2-oxido-1,3,2-oxazaphosphinan-2-yl)amine
NCGC00016639-01
NCGC00179435-01
NCI-C01638
NCI60_000233
NPFAPI-04
NSC 109,724
NSC 109724
NSC-109,724
NSC-109724
NSC109,724
NSC109724
Naxamide
Prestwick0_000833
Prestwick1_000833
Prestwick2_000833
Prestwick3_000833
S1302_Selleck
SMR001233348
SPBio_002706
STL058690
UNII-UM20QQM95Y
WLN: T6NPOTJ AM2G BO B2G
Z 4942
Z-4942
Z4942
ifosfamide
isosfamide
{3-(2-Chloroethyl)-2-[(2-chloroethyl)amino]perhydro-2H-1,
22
EtoposideapprovedPhase 1, Phase 2116933419-42-036462
Synonyms:
(-)-Etoposide
121471-01-0
136598-18-0
201594-04-9
33419-42-0
35317-32-9
4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside
4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside
4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin
4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside
4-Demethylepipodophyllotoxin-.beta.-D-ethylideneglucoside
51854-34-3
76576-58-4
9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-D)-1,3-dioxol-6(5ah)-one
AB00438905
AC1L1FN8
AC1L1VT3
AC1L6246
AC1NR4OG
AC1O4WGG
AC1O7M1N
AC1Q47JJ
Ambap33419-42-0
BPBio1_000673
BRD-K37798499-001-02-5
BSPBio_000611
Bio1_000489
Bio1_000978
Bio1_001467
C01576
CCRIS 2392
CHEBI:4911
CHEBI:588795
CHEMBL44657
CID11758093
CID284997
CID3310
CID36462
CID5284558
CID6419930
CID6610299
CPD000112002
D00125
DB00773
DEMETHY-EPIPODOPHYLLOTOXIN,ETHYLIDENE GLUCOSIDE,
Demethyl Epipodophyllotoxin Ethylidine Glucoside
Demethyl-epiodophyllotoxin ethylidene glucoside
Demethylepipodophyllotoxin-beta-D-ethylideneglucoside
E0675
E1383_SIGMA
EINECS 251-509-1
EPE
EPEG
ETOP
Epipodophyllotoxin
Epipodophyllotoxin VP-16213
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-.beta.-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside
Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside (8CI)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-.beta.-D-glucopyranoside)
Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside)
Eposide
Eposin
Eposin, Vepesid, VP-16, Toposar, Etoposide
 
Etopol
Etopophos
Etopophos (phosphate salt)
Etoposid
Etoposide
Etoposide (JP15/USP/INN)
Etoposide (VP16)
Etoposide Phosphate
Etoposide [USAN:INN:BAN:JAN]
Etoposido
Etoposido [INN-Spanish]
Etoposidum
Etoposidum [INN-Latin]
Etosid
HMS1569O13
HMS2052N05
HMS2089F14
HSDB 6517
I06-0248
KBioSS_002410
LS-1214
Lastet
MLS000049957
MLS001074951
MLS001424283
MLS002153463
MLS002207239
MLS002222184
MolPort-003-983-431
MolPort-004-905-001
MolPort-004-955-161
NCGC00025056-02
NChemBio.2007.10-comp19
NK 171
NSC 141540
NSC-141540
NSC141540
Prestwick0_000396
Prestwick1_000396
Prestwick2_000396
Prestwick3_000396
Prestwick_211
S1225_Selleck
SAM001246880
SMR000112002
SPBio_002532
ST056353
Toposar
UNII-6PLQ3CP4P3
VP 16
VP 16 (pharmaceutical)
VP 16-213
VP 16213
VP-16
VP-16-213
VePESID (TN)
VePesid
Vepesid
Vepesid J
Vepeside
ZINC03830818
ZINC03938684
Zuyeyidal
etoposide
nchembio.573-comp8
nchembio873-comp2
trans-Etoposide
23ImmunoglobulinsPhase 1, Phase 24477
24Isophosphamide mustardPhase 1, Phase 2371
25Calcium, DietaryPhase 24678
26Immunologic FactorsPhase 1, Phase 218483
27Antibodies, MonoclonalPhase 1, Phase 22413
28Alkylating AgentsPhase 1, Phase 23582
29AntibodiesPhase 1, Phase 24477
30Antineoplastic Agents, AlkylatingPhase 1, Phase 23406
31Etoposide phosphatePhase 1, Phase 21169

Interventional clinical trials:

(show all 14)
idNameStatusNCT IDPhase
1Effects of Rivastigmine Patch on Activities of Daily Living and Cognition in Patients With Severe Dementia of the Alzheimer's Type (ACTION) (Study Protocol CENA713DUS44, NCT00948766) and a 24 Week Open-label Extension to Study CENA713DUS44CompletedNCT00948766Phase 4
2Pre-operative Biliary SEMS RCT During Neoadjuvant TherapyRecruitingNCT02238847Phase 4
3Chemotherapy and Imatinib in Young Adults With Acute Lymphoblastic Leukemia Ph (BCR-ABL) POSITIVERecruitingNCT01491763Phase 4
4Study of the Safety and Effectiveness of SAMSCA® (Tolvaptan) in Children and Adolescents With Euvolemic or Hypervolemic HyponatremiaRecruitingNCT02012959Phase 3
5Cystic Fibrosis - Insulin Deficiency, Early ActionRecruitingNCT01100892Phase 3
6Multimodal Treatment of Phonological Alexia: Behavioral & fMRI OutcomesCompletedNCT00827268Phase 1, Phase 2
7Brentuximab Vedotin in Refractory/Relapsed Hodgkin Lymphoma Treated by ICERecruitingNCT02686346Phase 1, Phase 2
8Treatments of the Post-traumatic Necrosed Immature Teeth (REV)RecruitingNCT02064517Phase 2
9Therapy for Reading Problems in Adults After Brain InjuryCompletedNCT00064805
10Initiating and Maintaining Physical Activity in Depressed IndividualsRecruitingNCT02691845
11Preoperative Treatment With Noninvasive Intra-auricular Vagus Nerve Stimulation Pending Bariatric SurgeryRecruitingNCT02648191
12Brain Mechanisms Underlying Reading Improvement in Central AlexiaActive, not recruitingNCT02062619
13Effects of Music Education for Children With Reading DifficultiesActive, not recruitingNCT01388881
14App-delivered Therapy for Arabic Readers With Hemianopic AlexiaNot yet recruitingNCT02482350

Search NIH Clinical Center for Alexia


Cochrane evidence based reviews: dyslexia

Genetic Tests for Alexia

About this section

Anatomical Context for Alexia

About this section

MalaCards organs/tissues related to Alexia:

33
Brain, B cells, T cells, Thyroid, Lung, Tonsil, Colon

Animal Models for Alexia or affiliated genes

About this section

MGI Mouse Phenotypes related to Alexia:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053698.2APOE, PPP3CA, PSEN1, TARDBP
2MP:00036317.8APOE, MBP, PPP3CA, PSEN1, TARDBP
3MP:00053767.6APOE, MBP, PPP3CA, PSEN1, TARDBP
4MP:00107687.5APOE, MBP, PPP3CA, PSEN1, TARDBP
5MP:00053977.5APOE, MBP, PPP3CA, PSEN1, TARDBP
6MP:00053877.2APOE, MBP, PPP3CA, PSEN1, TARDBP

Publications for Alexia

About this section

Articles related to Alexia:

(show top 50)    (show all 309)
idTitleAuthorsYear
1
Glioblastoma Presenting with Pure Alexia and Palinopsia Involving the Left Inferior Occipital Gyrus and Visual Word Form Area Evaluated with Functional Magnetic Resonance Imaging and Diffusion Tensor Imaging Tractography. (26748167)
2016
2
Alexia Without Agraphia in a Right-Handed Individual Following Right Occipital Stroke. (26397830)
2015
3
Pure alexia after damage to the right fusiform gyrus in a right-handed male. (25440018)
2014
4
Progressive Wallerian Degeneration of the Corpus Callosal Splenium in a Patient with Alexia Without Agraphia: Advanced MR Findings. (25489886)
2014
5
On compensatory strategies and computational models: the case of pure alexia. (24863010)
2014
6
Temporal recruitment of cortical network involved in reading epilepsy with paroxysmal alexia: a combined EEG/MEG study. (23287492)
2013
7
Left- and right-hemisphere forms of phonological alexia. (23521052)
2012
8
The evolution of alexia in two cases of posterior cortical atrophy. (21876262)
2011
9
Damage to the upper portion of area 19 and the deep white matter in the left inferior parietal lobe, including the superior longitudinal fasciculus, results in alexia with agraphia. (20798545)
2010
10
Alexia and agraphia with lesions of the angular and supramarginal gyri: evidence for the disruption of sequential processing. (19896678)
2010
11
Neurophysiological correlates of post-hypnotic alexia: a controlled study with Stroop test. (20187340)
2010
12
Multiple Oral Re-reading treatment for alexia: The parts may be greater than the whole. (20574915)
2010
13
Hanja (Ideogram) alexia and agraphia in patients with semantic dementia. (19967597)
2010
14
Do dual-route models accurately predict reading and spelling performance in individuals with acquired alexia and agraphia? (17482218)
2007
15
Top-down and bottom-up effects in pure alexia: evidence from eye movements. (17433379)
2007
16
Large acute cerebral hemorrhage presenting with pure alexia. (17083996)
2007
17
Training phonological reading in deep alexia: does it improve reading words with low imageability? (17468994)
2007
18
Magnetic resonance tractography in a patient with alexia without agraphia. (16340212)
2005
19
Aphasia, alexia, and oral reading. (14872397)
2004
20
Alexia without agraphia in a postpartum eclamptic patient with factor V Leiden deficiency. (15037465)
2004
21
Braille alexia during visual hallucination in a blind man with selective calcarine atrophy. (12667171)
2003
22
Kinesthetic alexia due to left parietal lobe lesions. (12186998)
2002
23
Pure alexia in a Japanese-English bilingual: dissociation between the two languages. (11954857)
2002
24
Acquired alexia in multilingual aphasia and computer-assisted treatment in both languages: issues of generalisation and transfer. (11316940)
2001
25
Alexia without agraphia: a century later. (11351780)
2001
26
Alexia for Braille following bilateral occipital stroke in an early blind woman. (10674462)
2000
27
Can treatment for pure alexia improve letter-by-letter reading speed without sacrificing accuracy? (10210630)
1999
28
Could pure alexia be due to a disconnection syndrome? (9521304)
1998
29
Optic aphasia with pure alexia: a mild form of visual associative agnosia? A case study. (9669108)
1998
30
Evolution of a form of pure alexia without agraphia in a child sustaining occipital lobe infarction at 2 1/2 years. (9652784)
1998
31
Kanji-predominant alexia in advanced Alzheimer's disease. (9576638)
1998
32
Alexia without either agraphia or hemianopia in temporal lobe lesion due to herpes simplex encephalitis. (7550926)
1995
33
Alexia in dementia of the Alzheimer's type. (8116346)
1993
34
Pure alexia and right hemiachromatopsia in posterior dementia. (1619420)
1992
35
Posterior cortical dementia with alexia: neurobehavioural, MRI, and PET findings. (1865209)
1991
36
Alexia without agraphia: a new case studied by CT-scan. (2747903)
1989
37
Evidence for preserved reading in 'pure alexia'. (2706436)
1989
38
Alexia with agraphia due to the left posterior inferior temporal lobe lesion--neuropsychological analysis and its pathogenetic mechanisms. (3258777)
1988
39
Alexia without agraphia and associated disorders: importance of recognition in the rehabilitation setting. (3566519)
1987
40
Alexia without agraphia: clinical-computed tomographic correlations. (3614625)
1987
41
Palinoptic phenomena as an error mechanism in resolving alexia without agraphia. A case report. (4006994)
1985
42
Visual agnosia without alexia. (6539870)
1984
43
Jules Dejerine and the third alexia. (6367721)
1984
44
Vision-specific anomia and total involvement of splenium in alexia without agraphia. (7073541)
1982
45
Pure alexia in a Kannada-English bilingual. (7285592)
1981
46
Wernicke's and global aphasia without alexia. (435133)
1979
47
Alexia without agraphia: lateral and medial infarction of left occipital lobe. (571985)
1979
48
Phonological processing in reading: data from alexia. (533851)
1979
49
Does alexia without agraphia always include hemianopsia? (855643)
1977
50
The syndrome of alexia and amnesic aphasia; subarachnoidal haemorrhage with symptom of partial occlusion of the spinal subarachnoidal space. (18866783)
1948

Variations for Alexia

About this section

Expression for genes affiliated with Alexia

About this section
Search GEO for disease gene expression data for Alexia.

Pathways for genes affiliated with Alexia

About this section

Pathways related to Alexia according to GeneCards Suite gene sharing:

idSuper pathwaysScoreTop Affiliating Genes
19.5PPP3CA, PSEN1
29.5APOE, PSEN1
39.3MBP, PPP3CA
4
Show member pathways
9.0APOE, PPP3CA, PSEN1

GO Terms for genes affiliated with Alexia

About this section

Cellular components related to Alexia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1endoplasmic reticulumGO:00057839.5APOE, PSEN1

Biological processes related to Alexia according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1response to oxidative stressGO:00069799.2APOE, PSEN1
2negative regulation of protein phosphorylationGO:00019339.2PSEN1, TARDBP

Sources for Alexia

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet